Retina AI Unveils Clinical Evidence at American Society of Preventive Cardiology… Mediwhale Accelerates US Expansion

Mediwhale, a medical AI company, unveiled the clinical research results of its cardiovascular disease risk assessment AI solution, ‘Dr. Noon CVD,’ at a leading U.S. academic conference in the field of preventive cardiology. Along with the research presentation, the company engaged in academic exchanges with world-renowned cardiovascular experts, strengthening its clinical and academic networks for entry into the U.S. market. Mediwhale is set to expand into the global market for preventive medicine by simultaneously pursuing U.S. Food and Drug Administration (FDA) approval procedures and collaborating with local medical institutions.